Myers, Lynnea
Ho, Mai-Lan
Cauvet, Elodie
Lundin, Karl
Carlsson, Torkel
Kuja-Halkola, Ralf
Tammimies, Kristiina
Bölte, Sven
Article History
Received: 14 September 2020
Accepted: 15 December 2020
First Online: 29 December 2020
Competing interests
: M-L.H. is on the CLN2 Advisory Board for BioMarin Pharmaceuticals and receives book authorship royalties from McGraw-Hill. T.C. works as a child psychiatrist at PRIMA Psychiatry. S.B. discloses that he has in the last 5 years acted as an author, consultant or lecturer for Shire/Takeda, Medice, Roche, Eli Lilly, and Prima Psychiatry. S.B. receives royalties for textbooks and diagnostic tools from Huber/Hogrefe, Kohlhammer and UTB. L.M., E.C., K.L., R. K-H., and K.T. declare no potential conflicts of interest.